Skip to content
HomeLatest newsJohnson & Johnson Chairman and CEO Alex Gorsky appears on Bloomberg Big Decisions
David Westin and Johnson & Johnson Chairman and CEO Alex Gorsky Sat Down for An Interview for Bloomberg Big Decisions
David Westin (left) and Johnson & Johnson Chairman and CEO Alex Gorsky sat down for an interview for Bloomberg Big Decisions A.E. Fletcher Photography

Johnson & Johnson Chairman and CEO Alex Gorsky appears on Bloomberg Big Decisions

See what Alex Gorsky had to say about his goal to help change the trajectory of health for humanity—and how he believes the U.S. healthcare system must change for the better.

David Westin (left) and Johnson & Johnson Chairman and CEO Alex Gorsky sat down for an interview for Bloomberg Big Decisions A.E. Fletcher Photography

What do serving in the military and overseeing the world’s largest healthcare company have in common?

Both require that you earn the right to lead and fulfill your duty to those you serve—whether that’s your country or the patients, consumers, employees and stockholders you represent, says Johnson & Johnson Chairman and CEO Alex Gorsky, who served as a captain in the U.S. Army.

That’s just one of the insights he revealed last week during an interview with David Westin of Bloomberg Big Decisions that was filmed at the company’s new museum, where he answered tough questions on transparency in drug pricing and affordable healthcare—and explained why his biggest legacy will be to live up to Johnson & Johnson’s historic company code of conduct, the Credo.

Watch the full interview here on Bloomberg.com.


More from Johnson & Johnson

This scientist couldn’t save his father from lung cancer—but the targeted treatments Robert Zhao, Ph.D., has since developed have helped countless others

Learn more about Zhao, his partnership with Johnson & Johnson and antibody-drug conjugates—a new type of cancer therapy that targets and kills cancer cells without harming healthy cells.

After their husbands were diagnosed with multiple myeloma, these 3 care partners became health equity activists

Kimberly Alexander, Michelle Ware-Ivy and Marsha Calloway-Campbell learned firsthand that Black individuals develop multiple myeloma at higher rates. That’s why they joined Johnson & Johnson’s That’s My Word® health equity campaign, which builds awareness about the disparities surrounding this rare blood cancer.

How Johnson & Johnson is working to get medications to people around the world who need them most

In the just-released 2024 Access to Medicine Index, the company ranks among the top 5 improving access to medicines.